Influence of endothelin on human coronary arteries and localization of its binding sites.
Endothelin, a 21 amino acid peptide synthesized by cultured porcine aortic endothelial cells, has recently been identified and shown to produce a potent and prolonged constriction of mammalian blood vessels in vitro. Using tissue obtained from explanted hearts at the time of cardiac transplantation, the response of isolated human epicardial coronary arteries to endothelin was studied. The presence of endothelin binding sites was demonstrated in these vessels using an autoradiographic technique. Endothelin produced a dose-dependent increase of tension in the isolated coronary vessels with a maximal tension achieved equal to 135% of that induced by 90 mM of potassium. The maximal response was slow to develop and had a prolonged duration of 15 to 20 minutes. Nicardipine (4 microM) failed to affect the contraction induced by low doses of endothelin, but decreased the tension obtained at high doses. However, adenosine, substance P and glyceryl trinitrate were all effective in reversing the contraction induced by endothelin, while indomethacin and acetylcholine were ineffective. These features differ from those of other endogenous constrictor agents and make endothelin a potential candidate for long-term modulation of vascular tone.
Chester
A H
AH
National Heart and Lung Institute, Harefield Hospital, Middlesex, England.
Dashwood
M R
MR
Clarke
J G
JG
Larkin
S W
SW
Davies
G J
GJ
Tadjkarimi
S
S
Maseri
A
A
Yacoub
M H
MH
D001345:Autoradiography; D001665:Binding Sites; D003331:Coronary Vessels / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D016232:Endothelins; D004730:Endothelium, Vascular / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*; D014661:Vasoconstriction / Q000187:drug effects
D016232:Endothelins; D010455:Peptides